Filing Flows › Healthstream (HSTM) › Guidance & outlook
Healthstream (HSTM) guidance and outlook
Healthstream (HSTM) raised some and lowered other parts of its guidance on Nov 2, 2026: Capital expenditures $34.0M for FY2026; Revenue $327M–$332M for FY2026; Net income $19.5M–$22.2M for FY2026; EBITDA $74.0M–$78.0M for FY2026. Healthstream's 10-Q filed Nov 5, 2026 makes 6 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Capital expenditures | FY2026 | $34.0M | reaffirmed |
| Revenue | FY2026 | $327M–$332M | raised |
| Net income | FY2026 | $19.5M–$22.2M | lowered |
| EBITDA | FY2026 | $74.0M–$78.0M | raised |
| Interest expense | FY2026 | $100K | reaffirmed |
| Stock-based compensation | FY2026 | $5.0M | raised |
| Depreciation & amortization | FY2026 | $45.1M | lowered |
| EBITDA | FY2026 | $77.0M | raised |
From the earnings release filed Nov 2, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 5, 2026
- In addition, we expect to record sublease income, net, of approximately $0.8 million during the last three months of 2026 and $3.2 million annually thereafter for the remaining term of the sublease under the caption General and Administrative.
- The Company expects to incur additional costs as a result of this incident in future periods associated with ongoing cybersecurity monitoring and prevention as well as enhancements to the Company's cybersecurity program.
- Based on information currently known, this incident has not had, and the Company does not expect that this incident will have, a material adverse impact on the Company's business, operations, or financial results.
- The Company intends to use the net proceeds it received from the issuance of these shares for general corporate purposes, including continued investment in its solutions, working capital, potential acquisitions, and other strategic initiatives.
- T he dividend policy and the declaration and payment of each quarterly cash dividend will be subject to our Board’s continuing determination that the policy and the declaration and payment of dividends thereunder are in the best interests of our shareholders and are in compliance with applicable law and our credit agreement.
- There can be no assurance that amounts available for borrowing under our revolving credit facility will be sufficient to consummate any possible acquisitions, and we cannot provide assurance that if we need additional financing, it will be available on terms favorable to us or at all.
Healthstream's latest quarter
Healthstream, Q3 2026: revenue $83.3M (+9% year over year), operating margin 7.9%, net earnings $5.4M, operating cash flow $17.4M. The chart follows the revenue to costs, profit and cash.
Questions
Did Healthstream raise or lower its guidance?
Healthstream (HSTM) raised some and lowered other parts of its guidance on Nov 2, 2026: Capital expenditures $34.0M for FY2026; Revenue $327M–$332M for FY2026; Net income $19.5M–$22.2M for FY2026; EBITDA $74.0M–$78.0M for FY2026.
What does Healthstream expect?
In addition, we expect to record sublease income, net, of approximately $0.8 million during the last three months of 2026 and $3.2 million annually thereafter for the remaining term of the sublease under the caption General and Administrative. The Company expects to incur additional costs as a result of this incident in future periods associated with ongoing cybersecurity monitoring and prevention as well as enhancements to the Company's cybersecurity program. Based on information currently known, this incident has not had, and the Company does not expect that this incident will have, a materi
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.